Celldex Therapeutics (CLDX) Invested Capital (2009 - 2013)
Celldex Therapeutics (CLDX) recorded Invested Capital of $215.1 million in Q1 2013, up 74.8% from $123.07 million a year earlier and up 100.8% from the prior quarter.
Powered by 
Analysis
Celldex Therapeutics (CLDX) Invested Capital (2009 - 2013) Analysis & Trends
For FY2012, Celldex Therapeutics reported Invested Capital of $107.11 million, up 27.7% from FY2011.
- Across earlier years, Invested Capital came in at $83.87 million in FY2011 (-14.1%) and $97.67 million in FY2010.
- The Q1 2013 figure is the highest quarterly Invested Capital in data going back to Q4 2010.
- On a year-over-year basis, Invested Capital has increased for four consecutive quarters, with growth averaging 24.8% over the last five quarters.
- Per Business Quant, the preceding three quarters came in at $107.11 million (Q4 2012), $116.24 million (Q3 2012) and $122.35 million (Q2 2012).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 89.77 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 126.18 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 76.32 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 98.72 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 45.14 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 68.36 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 39.27 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 151.97 Bn |
| 10 | Celldex Therapeutics | 2.41 Bn | 69.14 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2013 | 215.10 Mn |
| Dec 31, 2012 | 107.11 Mn |
| Sep 30, 2012 | 116.24 Mn |
| Jun 30, 2012 | 122.35 Mn |
| Mar 31, 2012 | 123.07 Mn |
| Dec 31, 2011 | 83.87 Mn |
| Sep 30, 2011 | 95.78 Mn |
| Jun 30, 2011 | 107.07 Mn |
| Mar 31, 2011 | 84.12 Mn |
| Dec 31, 2010 | 97.67 Mn |
| Sep 30, 2010 | 50.95 Mn |
| Jun 30, 2010 | 58.83 Mn |
| Mar 31, 2010 | 66.07 Mn |
| Dec 31, 2009 | 85.63 Mn |
API Access
Celldex Therapeutics Invested Capital API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=invested-capital&ticker=CLDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "invested-capital", "ticker": "CLDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=invested-capital&ticker=CLDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();